Shirai Hiroki, Ikeda Kazuyoshi, Yamashita Kazuo, Tsuchiya Yuko, Sarmiento Jamica, Liang Shide, Morokata Tatsuaki, Mizuguchi Kenji, Higo Junichi, Standley Daron M, Nakamura Haruki
Molecular Medicine Research laboratories, Drug Discovery Research, Astellas Pharma Inc., 21, Miyukigaoka, Tsukuba-shi, Ibaraki, 305-8585, Japan.
Proteins. 2014 Aug;82(8):1624-35. doi: 10.1002/prot.24591. Epub 2014 May 13.
In the second antibody modeling assessment, we used a semiautomated template-based structure modeling approach for 11 blinded antibody variable region (Fv) targets. The structural modeling method involved several steps, including template selection for framework and canonical structures of complementary determining regions (CDRs), homology modeling, energy minimization, and expert inspection. The submitted models for Fv modeling in Stage 1 had the lowest average backbone root mean square deviation (RMSD) (1.06 Å). Comparison to crystal structures showed the most accurate Fv models were generated for 4 out of 11 targets. We found that the successful modeling in Stage 1 mainly was due to expert-guided template selection for CDRs, especially for CDR-H3, based on our previously proposed empirical method (H3-rules) and the use of position specific scoring matrix-based scoring. Loop refinement using fragment assembly and multicanonical molecular dynamics (McMD) was applied to CDR-H3 loop modeling in Stage 2. Fragment assembly and McMD produced putative structural ensembles with low free energy values that were scored based on the OSCAR all-atom force field and conformation density in principal component analysis space, respectively, as well as the degree of consensus between the two sampling methods. The quality of 8 out of 10 targets improved as compared with Stage 1. For 4 out of 10 Stage-2 targets, our method generated top-scoring models with RMSD values of less than 1 Å. In this article, we discuss the strengths and weaknesses of our approach as well as possible directions for improvement to generate better predictions in the future.
在第二次抗体建模评估中,我们对11个盲态抗体可变区(Fv)靶点采用了基于模板的半自动结构建模方法。结构建模方法包括几个步骤,包括框架模板选择和互补决定区(CDR)的典型结构、同源建模、能量最小化以及专家检查。在第一阶段提交的用于Fv建模的模型具有最低的平均主链均方根偏差(RMSD)(1.06 Å)。与晶体结构的比较表明,11个靶点中有4个生成了最准确的Fv模型。我们发现,第一阶段的成功建模主要归功于基于我们之前提出的经验方法(H3规则)对CDR进行专家指导的模板选择,尤其是对CDR-H3,以及使用基于位置特异性评分矩阵的评分。在第二阶段,使用片段组装和多规范分子动力学(McMD)进行环优化应用于CDR-H3环建模。片段组装和McMD分别基于OSCAR全原子力场和主成分分析空间中的构象密度以及两种采样方法之间的共识程度,生成了具有低自由能值的假定结构集合。与第一阶段相比,10个靶点中有8个的质量得到了改善。对于10个第二阶段靶点中的4个,我们的方法生成了RMSD值小于1 Å的高分模型。在本文中,我们讨论了我们方法的优缺点以及未来改进以产生更好预测的可能方向。